Effects of a human compact anti-ErbB2 antibody on gastric cancer

By Fedele Carmine   Carvalho Silvia   Riccio Gennaro   Paciello Rolando   Laccetti Paolo   Schmitt Fernando   De Lorenzo Claudia  

Gastric Cancer, Vol. 17, Iss. 1, 2014-01 ,pp. : 107-115

Springer Publishing Company

Access to resources Recommend Favorite

Transductional Efficacy and Safety of an Intraperitoneally Delivered Adenovirus Encoding an Anti-erbB-2 Intracellular Single-Chain Antibody for Ovarian Cancer Gene Therapy

By Deshane J.   Siegal G.P.   Wang M.   Wright M.   Bucy R.P.   Alvarez R.D.   Curiel D.T.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 378-385

Elsevier

Access to resources Recommend Favorite

Anti-erbB receptor strategy as a gene therapeutic intervention to improve radiotherapy in malignant human tumours

By Lammering G.   Hewit T. H.   Valerie K.   Lin P. S.   Contessa J. N.   Schmidt-Ullrich R. K.  

International Journal of Radiation Biology, Vol. 79, Iss. 7, 2003-07 ,pp. : 561-568

Informa Healthcare

Access to resources Recommend Favorite

Aggressive administration of recombinant oncotoxin AR209 (anti-ErbB-2) in athymic nude mice implanted with orthotopic human non-small cell lung tumours

By Skrepnik N.   Zieske A.W.   Robert E.   Bravo J.C.   Mera R.   Hunt J.D.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1628-1633

Elsevier

Access to resources Recommend Favorite

The Significance of Erb-b2 Immunostaining in Cervical Cancer

By Nevin J.   Laing D.   Kaye P.   McCulloch T.   Barnard R.   Silcocks P.   Blackett T.   Paterson M.   Sharp F.   Cruse P.  

Gynecologic Oncology, Vol. 73, Iss. 3, 1999-06 ,pp. : 354-358

Elsevier

Access to resources Recommend Favorite